The Banff 97 working classification of renal allograft pathology

Solez, 1993, International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology, Kidney Int, 44, 411, 10.1038/ki.1993.259 Corey, 1995, Renal allograft rejection in children and young adults: The Banff classification, Pediatr Nephrol, 9, 309, 10.1007/BF02254194 Gaber, 1996, Correlation between Banff classification, acute renal rejection scores and reversal of rejection, Kidney Int, 49, 481, 10.1038/ki.1996.68 Dittmer, 1995, Validation of the Banff Criteria for acute rejection in renal transplant biopsies, Aust N Z J Med, 25, 681, 10.1111/j.1445-5994.1995.tb02853.x Rush, 1995, Sequential protocol biopsies in renal transplant patients: Clinico-pathological correlations using the Banff schema, Transplantation, 59, 511, 10.1097/00007890-199502270-00012 Gaber, 1996, The correlation of Banff scoring with reversibility of first and recurrent rejection episodes, Transplantation, 61, 1711, 10.1097/00007890-199606270-00008 Croker, 1996, Macrophages and chronic renal allograft nephropathy, Kidney Int, 50, S42 Olsen Colvin, 1997, Evaluation of the pathologic criteria for acute renal allograft rejection: Reproducibility, sensitivity and clinical correlation, J Am Soc Nephrol, 8, 1930, 10.1681/ASN.V8121930 Solez, 1996, Report of the Third Banff Conference on Allograft Pathology (July 20–24, 1995) on classification and lesion scoring in renal allograft pathology, Transplant Proc, 28, 441 Trpkov, 1998, Effect of acute tubulitis and vasculitis on graft loss and early allograft function in patients treated with mycophenolate mofetil Nickeleit, 1998, The prognostic significance of significant arterial lesions in acute allograft rejection, J Am Soc Nephrol, 7, 1301, 10.1681/ASN.V971301 Halloran, 1998, Renal injury and preservation in transplantation, 149 Racusen, 1998, The pathology of kidney transplantation, 383 Raul, 1993, Diagnostic criteria for chronic rejection/accelerated graft atherosclerosis in heart and kidney transplants, Transplant Proc, 25, 2022 Mihatsch, 1993, Morphological criteria of chronic rejection: Differential diagnosis, including cyclosporine nephropathy, Transplant Proc, 25, 2031 Solez, 1996, Nephrotoxicity of cyclosporine and newer immunosuppressive agents, 587 Mihatsch, 1998, Histopathology of chronic rejection Finkelstein, 1976, Kidney transplant biopsies in the diagnosis and management of acute rejection reactions, Kidney Int, 10, 171, 10.1038/ki.1976.92 Banfi, 1981, Prognostic value of renal biopsy in acute rejection of kidney transplantation, Nephron, 28, 222, 10.1159/000182204 Matas, 1983, The value of needle renal allograft biopsy. I. A retrospective study of biopsies performed during putative rejection episodes, Ann Surg, 197, 226, 10.1097/00000658-198302000-00017 Visscher, 1991, Histologic and immunophenotypic evaluation of pretreatment renal biopsies in OKT3-treated allograft rejections, Transplantation, 51, 1023, 10.1097/00007890-199105000-00018 Schroeder, 1991, The efficacy of OKT3 in vascular rejection, Transplantation, 51, 312, 10.1097/00007890-199102000-00007 Burdick, 1984, Characteristics of early routine renal allograft biopsies, Transplantation, 38, 679, 10.1097/00007890-198412000-00026 Solez, 1993, Morphology of ischemic acute renal and cyclosporine toxicity in cyclosporine-treated renal allograft recipients, Kidney Int, 43, 1058, 10.1038/ki.1993.148 Rush, 1996, Effect of subclinical rejection on renal allograft histology and function at 6months, Transplant Proc, 18, 494 Rush, 1998, Beneficial effects of treatment of early subclinical rejection: A randomized study, J Am Soc Nephrol, 7, 2129, 10.1681/ASN.V9112129 Schweitzer, 1996, Significance of the Banff borderline biopsy, Am J Kidney Dis, 28, 585, 10.1016/S0272-6386(96)90471-0 Morrissey, 1997, Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria, Transplantation, 63, 845, 10.1097/00007890-199703270-00009 Saad, 1997, Clinical significance of renal allograft biopsies with “borderline changes,” as defined in the Banff schema, Transplantation, 64, 992, 10.1097/00007890-199710150-00010 Furness, 1997, A UK-wide trial of the Banff classification of renal transplant pathology in routine diagnostic practice, Nephrol Dial Transplant, 12, 995, 10.1093/ndt/12.5.995 Tanabe, 1996, Clinicopathologic analysis of rejection episodes in ABO-incompatible kidney transplantation, Transplant Proc, 28, 1447 Trpkov, 1992, The significance of the anti-class I response II: Clinical and pathologic features of renal transplants with anti-class I-like antibody, Transplantation, 53, 550 Bohle, 1992, The long-term prognosis of the primary glomerulonephritides: A morphological and clinical analysis of 1748 cases, Pathol Res Pract, 188, 908, 10.1016/S0344-0338(11)80252-9 Isoniemi, 1994, Histopathologic chronic allograft damage index accurately predicts chronic renal allograft rejection, Transplantation, 58, 1195 Platt, 1985, Interstitial nephritis associated with cytomegalovirus infection, Kidney Int, 28, 550, 10.1038/ki.1985.163 Pappo, 1996, Human polyoma virus infection of renal allografts: Histopathologic diagnosis, clinical significance and literature review, Mod Pathol, 9, 105 Ito, 1991, Necrotizing tubulointerstitial nephritis associated with adenovirus infection, Hum Pathol, 22, 1225, 10.1016/0046-8177(91)90104-W Colvin, 1996, The renal allograft biopsy, Kidney Int, 50, 1069, 10.1038/ki.1996.410 Randhawa, 1996, Histopathology of renal post-transplant lymphoproliferation: Comparison with rejection using the Banff Schema, Am J Kidney Dis, 28, 578, 10.1016/S0272-6386(96)90470-9 Trpkov, 1997, Kidney allograft rejection, post-transplant lymphoproliferative disorder, neither, or both entities, Am J Kidney Dis, 30, 449, 10.1016/S0272-6386(97)90295-X Deamant, 1993, Epstein-Barr virus distribution in neoplastic lymph nodes, Mod Pathol, 6, 729 Seiden, 1993, Molecular genetic analysis of posttransplant lymphoproliferative disorders, Hematol Oncol Clin North Am, 7, 447, 10.1016/S0889-8588(18)30251-X Randhawa, 1993, The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506, Am J Surg Pathol, 17, 60, 10.1097/00000478-199301000-00007 Japanese FK506 Study Group, 1993, Morphological characteristics of renal allografts showing renal dysfunction under FK506: Is graft biopsy available to reveal the morphological findings corresponding with FK506 nephropathy?, Transplant Proc, 25, 624 Randhawa, 1996, Microvascular changes in renal allografts associated with FK506 (Tacrolimus) therapy, Am J Surg Pathol, 20, 306, 10.1097/00000478-199603000-00007 Randhawa, 1997, Tacrolimus (FK506) associated renal pathology, Adv Anat Pathol, 4, 265, 10.1097/00125480-199707000-00032 Stillman, 1995, FK506 nephrotoxicity: Morphologic and physiologic characterization of a rat model, Lab Invest, 73, 794 Seron, 1997, Early protocol renal allograft biopsies and graft outcome, Kidney Int, 51, 310, 10.1038/ki.1997.38 Nickerson, 1998, Identification of clinical and histopathologic risk factors for diminished renal function 2years post-transplant, J Am Soc Nephrol, 19, 482, 10.1681/ASN.V93482 Strehlau, 1997, Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation, Proc Natl Acad Sci USA, 94, 695, 10.1073/pnas.94.2.695